Cantor Fitzgerald Downgrades Aurora Cannabis to Neutral, Lowers Price Target to C$7
Cantor Fitzgerald analyst Pablo Zuanic downgrades Aurora Cannabis (TSX:ACB) from Overweight to Neutral and lowers the price target from C$18 to C$7.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Cantor Fitzgerald Maintains Overweight on OrganiGram Holdings, Lowers Price Target to C$3
Cantor Fitzgerald analyst Pablo Zuanic maintains OrganiGram Holdings (TSX:OGI) with a Overweight and lowers the price target from C$5.35 to C$3. read more
420 Investor: 'This Is The Most Excited I've Ever Been' In Cannabis
Alan Brochstein, author of 420 Investor and founding partner of New Cannabis Ventures, says the recent political momentum behind the cannabis legalization push in the US — and the resulting rebound in cannabis stocks since the U.S. election — has him feeling extremely optimistic about the industry's future. read more
Canadian Cannabis Stocks Are Becoming Less Desirable Investments, Data Suggests
Cannabis stocks have taken a hit since Election Day, Nov. 3. The latest Hifyre cannabis sales data out of Canada suggests some concerning trends in the market. The Numbers: Month-over-month, Canadian retail cannabis sales were up just 4% in October and down 3% in November, Hifyre estimates. read more
PreMarket Prep Stock Of The Day: GW Pharmaceuticals
Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session. read more